Your browser doesn't support javascript.
loading
Cabozantinib inhibits prostate cancer growth and prevents tumor-induced bone lesions.
Dai, Jinlu; Zhang, Honglai; Karatsinides, Andreas; Keller, Jill M; Kozloff, Kenneth M; Aftab, Dana T; Schimmoller, Frauke; Keller, Evan T.
Affiliation
  • Dai J; Authors' Affiliations: Departments of Urology and Orthopaedic Surgery, University of Michigan, Ann Arbor, Michigan; and Exelixis Inc., South San Francisco, California.
Clin Cancer Res ; 20(3): 617-30, 2014 Feb 01.
Article in En | MEDLINE | ID: mdl-24097861
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Osteoblasts / Prostatic Neoplasms / Pyridines / Bone Neoplasms / Cell Proliferation / Anilides / Antineoplastic Agents Type of study: Prognostic_studies Limits: Animals / Humans / Male Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2014 Document type: Article Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Osteoblasts / Prostatic Neoplasms / Pyridines / Bone Neoplasms / Cell Proliferation / Anilides / Antineoplastic Agents Type of study: Prognostic_studies Limits: Animals / Humans / Male Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2014 Document type: Article Country of publication: United States